Guardian Capital (Canada)’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.12M Sell
23,200
-4,000
-15% -$1.11M 0.12% 89
2026
Q1
$8.03M Sell
27,200
-11,900
-30% -$3.53M 0.21% 76
2025
Q4
$10.7M Sell
39,100
-15,660
-29% -$4.26M 0.32% 61
2025
Q3
$14.8M Buy
54,760
+9,860
+22% +$2.68M 0.48% 54
2025
Q2
$12.4M Hold
44,900
0.44% 59
2025
Q1
$11.9M Sell
44,900
-719
-2% -$177K 0.47% 57
2024
Q4
$10.6M Sell
45,619
-1,300
-3% -$299K 0.39% 62
2024
Q3
$10.4M Sell
46,919
-1,000
-2% -$207K 0.38% 61
2024
Q2
$9.42M Hold
47,919
0.36% 60
2024
Q1
$10.3M Sell
47,919
-498
-1% -$105K 0.36% 60
2023
Q4
$10.2M Buy
48,417
+2,000
+4% +$427K 0.37% 58
2023
Q3
$9.29M Sell
46,417
-2,097
-4% -$417K 0.35% 61
2023
Q2
$8.99M Buy
48,514
+4,800
+11% +$887K 0.29% 63
2023
Q1
$8.37M Sell
43,714
-4,282
-9% -$774K 0.27% 70
2022
Q4
$8.07M Buy
47,996
+2,101
+5% +$365K 0.27% 68
2022
Q3
$8.13M Buy
45,895
+595
+1% +$118K 0.28% 66
2022
Q2
$9.27M Buy
45,300
+5,100
+13% +$1.08M 0.28% 69
2022
Q1
$9.56M Buy
40,200
+14,600
+57% +$3.43M 0.19% 74
2021
Q4
$5.85M Buy
25,600
+2,300
+10% +$506K 0.11% 82
2021
Q3
$4.51M Buy
23,300
+1,400
+6% +$284K 0.09% 88
2021
Q2
$4.66M Buy
21,900
+3,700
+20% +$781K 0.09% 90
2021
Q1
$3.72M Buy
18,200
+5,400
+42% +$1.06M 0.06% 91
2020
Q4
$2.33M Buy
12,800
+2,100
+20% +$357K 0.05% 90
2020
Q3
$1.79M Sell
10,700
-52,499
-83% -$8.84M 0.05% 91
2020
Q2
$10.3M Buy
63,199
+4,020
+7% +$721K 0.27% 64
2020
Q1
$10.2M Sell
59,179
-1,363
-2% -$271K 0.3% 56
2019
Q4
$12.2M Sell
60,542
-10,849
-15% -$2.23M 0.25% 60
2019
Q3
$15.1M Buy
71,391
+10,612
+17% +$2.22M 0.3% 63
2019
Q2
$11.8M Buy
60,779
+2,812
+5% +$518K 0.23% 71
2019
Q1
$9.54M Buy
57,967
+25,871
+81% +$4.57M 0.18% 77
2018
Q4
$6.04M Buy
+32,096
New +$5.93M 0.13% 83
2017
Q4
Sell
-98,242
Closed -$13.3M 189
2017
Q3
$13.3M Buy
98,242
+5,908
+6% +$746K 0.2% 71
2017
Q2
$11.6M Buy
92,334
+18,778
+26% +$2.25M 0.18% 79
2017
Q1
$8.74M Buy
73,556
+9,203
+14% +$1.11M 0.13% 93
2016
Q4
$7.42M Buy
64,353
+6,368
+11% +$709K 0.11% 98
2016
Q3
$6.06M Buy
57,985
+7,187
+14% +$750K 0.1% 103
2016
Q2
$4.95M Buy
50,798
+17,713
+54% +$1.67M 0.08% 106
2016
Q1
$3.18M Buy
33,085
+10,920
+49% +$993K 0.05% 112
2015
Q4
$2.01M Buy
22,165
+13,718
+162% +$1.29M 0.04% 121
2015
Q3
$783K Buy
8,447
+520
+7% +$49.4K 0.01% 141
2015
Q2
$738K Sell
7,927
-3,054
-28% -$285K 0.01% 149
2015
Q1
$1.04M Sell
10,981
-712
-6% -$66K 0.02% 142
2014
Q4
$1.04M Buy
+11,693
New +$991K 0.02% 131

Other funds holding CME

Guardian Capital (Canada)'s CME Position: Q2 2026 in Review

Guardian Capital (Canada) reduced its CME Group (CME) stake by 15% in Q2 2026, selling an estimated $1.11M and leaving 23,200 shares worth $5.12M. The position accounts for 0.12% of the portfolio, ranked #89.

Guardian Capital (Canada) first reported a position in CME in Q4 2014 and has held it in 43 quarters since. The position peaked at $15.1M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Guardian Capital (Canada) held 23,200 shares of CME Group worth $5.12M as of Q2 2026.
  • Guardian Capital (Canada) sold 4,000 CME Group shares in Q2 2026, an estimated $1.11M.
  • CME Group made up 0.12% of Guardian Capital (Canada)'s portfolio in Q2 2026, its #89 holding.
  • Guardian Capital (Canada) first reported a position in CME Group in Q4 2014 and has held it in 43 quarters since.
  • Guardian Capital (Canada)'s CME Group position peaked at $15.1M in Q3 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2026, filed 14 Aug 2026.